A0A0S2Z4T6 (A0A0S2Z4T6_HUMAN) Homo sapiens (Human)
Phosphodiesterase UniProtKBInterProInteractive Modelling
593 aa; Sequence (Fasta) ;
1 identical sequence: Homo sapiens: O76083
It is possible new templates exist for this target since these models were created.
Available Structures
25 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| Crystal structure of PDE9 in complex with racemic inhibitor C33 | homo-2-mer | 1×49D; 2×ZN; 2×MG; 1×49E; | ||||
| Assess | ||||||
| Crystal structure of the PDE9A catalytic domain in complex with inhibitor 28 | homo-2-mer | 3×LUO; 2×ZN; 2×MG; | ||||
| Assess | ||||||
| Crystal structure of phosphodiesterase 9 in complex with (S)-C33 | homo-2-mer | 2×49D; 2×ZN; 2×MG; | ||||
| Assess | ||||||
| Crystal structure of PDE9A (E406A) mutant in complex with IBMX | homo-2-mer | 2×IBM; 2×ZN; 2×MG; 1×CL; | ||||
| Assess | ||||||
| Crystal structure of the human Phosphodiesterase 9A catalytic domain complexed with IBMX | homo-2-mer | 2×ZN; 2×MG; 2×IBM; | ||||
| Assess | ||||||
| Crystal structure of phosphodiesterase 9 in complex with (R)-C33 (6-{[(1R)-1-(4-chlorophenyl)ethyl]… | homo-2-mer | 2×49E; 2×ZN; 2×MG; | ||||
| Assess | ||||||
| Crystal structure of PDE9A(Q453E) in complex with inhibitor BAY73-6691 | homo-2-mer | 2×PDB; 2×ZN; 2×MG; | ||||
| Assess | ||||||
| Crystal structure of PDE9A(Q453E) in complex with IBMX | homo-2-mer | 2×IBM; 2×ZN; 2×MG; | ||||
| Assess | ||||||
| human phosphodiestrase-5'GMP complex (EP), produced by soaking with 20mM cGMP+20 mM MnCl2+20 mM MgC… | homo-2-mer | 4×MN; 2×MG; 1×5GP; 1×IBM; 1×FMT; | ||||
| Assess | ||||||
| Human PDE9 in complex with selective inhibitor | homo-2-mer | 2×ZN; 2×MG; 2×JAR; | ||||
| Assess | ||||||
| human phosphodiestrase 9 (inhibited by omitting divalent cation) in complex with cGMP | homo-2-mer | 4×NA; 1×PCG; 1×IBM; | ||||
| Assess | ||||||
| Crystal structure of the PDE9 catalytic domain in complex with inhibitor 2 | homo-2-mer | 2×ZN; 2×MG; 2×9Q9; | ||||
| Assess | ||||||
| Crystal structure of the PDE9 catalytic domain in complex with inhibitor 4a | homo-2-mer | 2×ZN; 2×MG; 2×EZU; | ||||
| Assess | ||||||
| Crystal structure of the PDE9A catalytic domain in complex with (S)-BAY73-6691 | homo-2-mer | 2×ZN; 2×MG; 2×BYE; | ||||
| Assess | ||||||
| Crystal structure of the PDE9A catalytic domain in complex with (R)-BAY73-6691 | homo-2-mer | 2×ZN; 2×MG; 2×PDB; | ||||
| Assess | ||||||
| X-RAY STRUCTURE OF PDE9A IN COMPLEX WITH Inhibitor 13A | homo-2-mer | 2×ZN; 2×MG; 2×NA; 1×R4I; | ||||
| Assess | ||||||
| Crystal structure of PDE9 in complex with IBMX | monomer | 1×ZN; 1×MG; 1×IBM; | ||||
| Assess | ||||||
| human phosphodiestrase 9 in complex with cGMP (Zn inhibited) | monomer | 1×ZN; 1×MG; 1×PCG; | ||||
| Assess | ||||||
| Human Phosphodiesterase 9 in complex with product 5'-GMP (E+P complex) | monomer | 1×MN; 1×MG; 1×5GP; | ||||
| Assess | ||||||
| Human pde9 in complex with selective compound | monomer | 1×ZN; 1×MG; 1×0WF; | ||||
| Assess | ||||||
| Human phosphodiesterase 9 in complex with inhibitors | monomer | 1×ZN; 1×MG; 1×7RG; | ||||
| Assess | ||||||
| human phosphdiesterase 9 substrate complex (ES complex) | monomer | 1×MN; 1×MG; 1×PCG; | ||||
| Assess | ||||||
| Human phosphodiesterase 9 in complex with inhibitor | monomer | 1×ZN; 1×MG; 1×WTC; | ||||
| Assess | ||||||
| Human PDE9 in complex with selective compound | monomer | 1×ZN; 1×MG; 1×0WL; | ||||
| Assess | ||||||
| phosphodiesterase-9A in complex with inhibitor 4b | monomer | 1×ZN; 1×MG; 1×06A; | ||||
| Assess | ||||||
1 SWISS-MODEL model
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 4y86.1.A | homo-2-mer | 0.91 | 1×49D; 2×ZN; 1×MG; 1×49E; | 94.18 | ||
| Assess | ||||||